A very small amount (0.0005 to 0.001%) of an ammonium sulfate [50%o saturated (NH4)2SO41-precipitable protein fraction of c2-globulin efficiently supported inflammation-primed activation of macrophages. This fraction contains vitamin D3-binding protein essential for macrophage activation. Comparative macrophage activation studies with fetal calf serum, a2-globulin fraction, 50%o (NH4)2S04 precipitate, and purified bovine vitamin D3-binding protein revealed that fetal calf serum and %-globulin fraction appear to contain an inhibitor for macrophage activation while ammonium sulfate precipitate contains no inhibitor. This inhibitor was found to be serum albumin. When bovine serum albumin (25 ,ug/ml) was added to a medium supplemented with 0.0005 to 0.05% (NH4)2SO4 precipitate or 1 to 10 ng of vitamin D3-binding protein per ml, activation of macrophages was inhibited.
Microbial infections cause inflammation. Inflamed lesions attract and activate phagocytes and induce immunity against the infectious agents, implying that biochemical signals should be radiating from the inflamed lesions. The inflamed tissues release lysophospholipids and alkylglycerols, which are potent chemotactic and macrophage-stimulating agents (10, 11, 17, 19) . Administration of lysophospholipids or alkylglycerols to mice activates macrophages to phagocytize target antigens or cells via the Fc receptor (10, 11, 17, 19) and to generate superoxide (18) . In vitro treatment of mouse peritoneal cells (mixture of adherent and nonadherent cells) with lysophosphatidylcholine (lyso-Pc) or dodecylglycerol (DDG) for a few hours produced a markedly enhanced Fc receptor-mediated phagocytic activity of macrophages (12, 18, 19) . Treatment of adherent cells (macrophages) alone with lyso-Pc or DDG resulted in no activation of macrophages. Inflammation-primed activation of macrophages requires the participation of B and T lymphocytes (12, 18, 19) and vitamin D3-binding protein (DBP; human DBP is known as group-specific component or Gc) (14) (15) (16) . DBP can be converted to a potent macrophage-activating factor by stepwise interaction with 3-galactosidase of lysoPc-or DDG-treated B cells and sialidase of untreated T cells (14) . Thus, DBP is a precursor of macrophage-activating factor (14) .
A comparative analysis of the precursor activities of purified human DBP (Gc protein) and adult human serum was performed. The highest level of macrophage activation can be achieved with 0.1% adult human serum-supplemented RPMI 1640 medium and with about 0.26 ng of Gc protein per ml in 0.1% egg albumin-supplemented RPMI 1640 medium (EA medium) (15, 16) . Since the Gc protein concentration in 0.1% adult human serum is about 260 ng/ml, the concentration of Gc protein in whole serum required for * Corresponding author. efficient activation of macrophages is about 1,000-fold-higher than that of purified Gc protein. Thus, the macrophageactivating factor is more efficiently generated from purified Gc protein than from the same protein in whole serum, and generation of the macrophage-activating factor from Gc protein is less efficient in the presence of other serum proteins (15, 16) . We propose that a serum factor(s) appears to be inhibitory to the macrophage activation process.
We fractionated fetal calf serum (FCS) by ammonium sulfate precipitation. Two milliliters of saturated ammonium sulfate was added to 2 ml of gamma globulin-free FCS (GIBCO, Gaithersburg, Md.), and the mixture was incubated for 1 h at room temperature. Supernatant and precipitate were separated by centrifugation (8,500 x g) for 10 min. The pellet was suspended in 1 to 1.5 ml of saline (0.85% NaCl) and dialyzed three times against a large volume (500 ml) of saline at 4°C. The dialyzed fraction was adjusted by adding saline to yield the same volume (2 ml) as the original volume of serum used for ammonium sulfate precipitation. Thus, the concentration of the protein of interest per volume corresponded to that in the original serum. Supematant was also dialyzed against saline. a2-Globulin was fractionated by starch block electrophoresis (7, 16 hanced phagocytic activity, while the supernatant did not. A small amount (0.001%, vol/vol) of the precipitate efficiently supported lyso-Pc-or DDG-primed activation of macrophages, while 1% FCS was required for the same extent of macrophage activation (Table 1, lines 3 and 5) . Thus, the strikingly increased activity of the serum factor after ammonium sulfate fractionation suggests that this procedure separates the precursor of macrophage-activating factor from the inhibitor(s). In separate studies with electrophoretic serum fractionation, we found that a serum factor in the a2-globulin fraction is essential for the activation process of macrophages after lyso-Pc or DDG treatment of peritoneal cells and that a precursor of the macrophage-activating factor exists in the a2-globulin fraction (7, 16 be essential for the activation of macrophages (14, 16) . bDBP can be depleted from FCS and a2-globulin fraction by treatment with anti-bDBP immunoglobulin G, as described previously (16) . The bDBP-depleted FCS and a2-globulin fraction did not support lyso-Pc-primed activation of macrophages, as shown in Table 2 . Thus, DBP is the sole serum component required for macrophage activation. When we purified bDBP from FCS by the method of Link et al. (9) and added various concentrations of bDBP to the bDBP-depleted FCS and a2-globulin fraction, lyso-Pc-primed activation of macrophages could be supported. Although 10 ng of purified bDBP per ml produced a greatly enhanced phagocytic activity, a large amount of bDBP (2.6 jig/ml), equivalent to that found in 1% FCS, was required for the bDBP-depleted FCS to activate macrophages (Table 2) . bDBP-depleted a2-globulin fraction also required about 130 ng of bDBP per ml for lyso-Pc-primed activation of macrophages. These results imply that a large amount of inhibitor is present in FCS while some inhibitor is contained in the electrophoretic a2-globulin fraction.
Human Gc protein was shown to be precipitable by treatment of whole serum with 50% saturated ammonium sulfate (5, 16) . Although 50% saturated ammonium sulfate ordinarily precipitates larger serum proteins, but not smaller proteins such as albumin, this procedure appeared to precipitate bDBP. As shown in Table 3 , a very small amount (as low as 0.0005%, vol/vol) of 50% ammonium sulfate precipitate in culture medium efficiently supported lyso-Pc-primed macrophage activation, as demonstrated by a greatly increased superoxide-generating capacity. This level of macrophage activation cannot be achieved by a medium supplemented with 1 to 10% FCS (Table 4) . Thus, ammonium sulfate precipitation greatly increases the macrophage-activating capacity of the serum factor. Therefore, it is possible that the supematant fraction may contain an inhibitor of absence of BSA (25 ,g/ml). After 3 h of cultivation, the superoxide-generating capacity of macrophages was determined. The BSA concentration corresponds to that in 0.1% FCS (see Table 4 ). Values represent means + standard errors of triplicate assays. The results were reproduced at least three times.
macrophage activation. When the supematant was added to the precipitate, a greatly reduced superoxide generation of macrophages was observed (Table 3) . Since DBP and serum albumin share extensive similarity in three-dimensional configuration (3, 4, 20, 21) , various amounts of 50% saturated ammonium sulfate precipitate and 25 ,ug of bovine serum albumin (BSA) per ml were added to EA medium for 3 h of cocultivation of lyso-Pc-treated nonadherent cells and untreated adherent cells. As shown in Table 3 , the capacity of 50% saturated ammonium sulfate precipitate to support macrophage activation was inhibited by the presence of BSA.
To substantiate these observations further, bDBP was purified from the 50% saturated ammonium sulfate precipitate of FCS. The dose effect of bDBP was studied for comparison with that of the ammonium sulfate precipitate. Lyso-Pc-treated nonadherent cells were cocultured for 3 h with untreated adherent cells in EA medium containing various concentrations (0.1 to 20 ng/ml) of bDBP. As can be seen in Table 5 , experiment 1, purified bDBP at concentrations as low as 1 to 2 ng/ml produced greatly enhanced macrophage activation. As the concentration of bDBP was increased up to 20 ng/ml, lyso-Pc-primed activation of macrophages for superoxide generation increased. Since the bDBP concentration of the 0.0005% ammonium sulfate precipitate is about 1.3 ng/ml, the macrophages are as efficiently activated in the presence of the ammonium sulfate precipitate of FCS as with purified bDBP, as summarized in Table   TABLE 4 b Untreated nonadherent cells were cultured with untreated adherent cells.
6. These findings suggest that the generation of the macrophage-activating factor from bDBP is equally efficient in the presence of other serum proteins in the ammonium sulfate precipitate, suggesting that no inhibitor is detectable in the ammonium sulfate precipitate. When BSA (25 ,ug/ml) was added to EA medium supplemented with 1 or 10 ng of bDBP per ml for cultivation of lyso-Pc-treated peritoneal cells, the activation of macrophages was greatly inhibited (Table 5,  experiment 2) . Therefore, we conclude that serum albumin inhibits inflammation-primed activation of macrophages, possibly competitively with DBP. The gene encoding human DBP (i.e., Gc protein) is located on human chromosome 4 and is linked to the albumin gene (4) . These genes have evolved from a smaller ancestral gene by intragenic triplication and by intergenic duplication. Human, rat, and mouse DBPs share significant amino acid sequence homology and nucleotide sequence homology with the albumin of their respective species (3, 4, 20, 21) . A conserved pattern of disulfide bridges forms triple-domain structures in DBP and albumin. Because of the structural similarity, serum albumin appears to compete with DBP in the activation of macrophages.
